Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Non-cash Items (2016 - 2023)

Iradimed (IRMD) has disclosed Non-cash Items for 10 consecutive years, with $3010.0 as the latest value for Q4 2023.

  • Quarterly Non-cash Items fell 87.46% to $3010.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $3010.0 through Dec 2023, down 87.46% year-over-year, with the annual reading at $3010.0 for FY2023, 87.46% down from the prior year.
  • Non-cash Items for Q4 2023 was $3010.0 at Iradimed, down from $24010.0 in the prior quarter.
  • The five-year high for Non-cash Items was $4.1 million in Q3 2019, with the low at $3010.0 in Q4 2023.
  • Average Non-cash Items over 5 years is $1.5 million, with a median of $1.3 million recorded in 2019.
  • The sharpest move saw Non-cash Items skyrocketed 2677.86% in 2019, then plummeted 87.46% in 2023.
  • Over 5 years, Non-cash Items stood at $538991.0 in 2019, then crashed by 57.23% to $230510.0 in 2020, then tumbled by 82.83% to $39576.0 in 2021, then plummeted by 39.33% to $24010.0 in 2022, then tumbled by 87.46% to $3010.0 in 2023.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $3010.0, $24010.0, and $39576.0 for Q4 2023, Q4 2022, and Q4 2021 respectively.